
Saving lives while helping the planet
2 June 2025
Construction and traffic reorganization at the Glen site. Traffic delays expected.
More infoSTM strike: June 9 to 17. Find out how your bus and metro trips will be affected.
Read more4 October 2024
As of November 1, 2024, a new medication called nirsevimab will be available in Quebec to prevent respiratory syncytial virus (RSV).
RSV is a common, highly contagious respiratory virus, infecting nearly all children by two years of age.
It is the most common cause of bronchiolitis and pneumonia in children less than one year of age.
A Quebec-based study found RSV was the most common virus (63.6 per cent) in children hospitalized for acute respiratory infection, with higher severity in children born prematurely and babies under six months of age (Papenburg et al, 2012).
Nirsevimab will be available at CLSCs and local points of service for:
How is it given?
Nirsevimab is administered at the start/during RSV season as an intramuscular injection, usually in the thigh muscle.
Where will it be given?
Don’t hesitate to book an appointment for your child!
Saving lives while helping the planet
2 June 2025
My spine is curvy, let’s talk about it!
11 March 2025
Upcoming winter storm raises alarms at MCH Trauma Centre
12 February 2025